PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN
Abstract
Authors
de Ramirez A Arellano U Sbarigia MJ Taylor P Martin G Restovic
de Ramirez A Arellano U Sbarigia MJ Taylor P Martin G Restovic
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now